StockData
Addex Therapeutics Ltd. logo

Addex Therapeutics Ltd. (ADXN) stock

ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on May 15, 2026Score 0/30
$3.50−0.33 (-8.62%)

Close on Nov 17, 2026Market cap $71.86KP/E –Yield –

Addex Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Addex Therapeutics's total assets was CHF 3.48M at Jun 30, 2026. For fiscal 2025 it was CHF 6.36M, down 40.4% from the year before. The highest annual figure on record is CHF 42.21M in fiscal 2018.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025CHF 6.36M-40.4%
FY2024Dec 31, 2024CHF 10.68M+130.0%
FY2023Dec 31, 2023CHF 4.64M-44.0%
FY2022Dec 31, 2022CHF 8.28M-63.3%
FY2021Dec 31, 2021CHF 22.54M+11.7%
FY2020Dec 31, 2020CHF 20.18M-38.9%
FY2019Dec 31, 2019CHF 33.03M-21.8%
FY2018Dec 31, 2018CHF 42.21M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026CHF 3.48M-25.0%
Q4 FY2025Dec 31, 2025CHF 6.36M-29.3%
Q2 FY2025Jun 30, 2025CHF 8.51M+2.7%
Q4 FY2024Dec 31, 2024CHF 10.68M-6.2%
Q4 FY2023Dec 31, 2023CHF 4.64M-79.4%
Q2 FY2023Jun 30, 2023CHF 9.00M-55.4%
Q4 FY2022Dec 31, 2022CHF 8.28M-74.9%
Q2 FY2022Jun 30, 2022CHF 11.38M-73.0%
Q4 FY2021Dec 31, 2021CHF 22.54M–
Q4 FY2020Dec 31, 2020CHF 20.18M–
Q4 FY2019Dec 31, 2019CHF 33.03M–
Q4 FY2018Dec 31, 2018CHF 42.21M–

More Addex Therapeutics figures

See a number that looks wrong?